Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
text
Tags
amgen
artificial intelligence
ayasdi
biotechnology
boston blog main
boston top stories
butterfly network
cholesterol
clinical trials
data
deep learning
drug discovery
enlitic
google
ibm
inclisiran
ldl
life sciences
lumiata
machine-learning
mark timney
medical data
mt sinai hospital
national blog main
national top stories
new york
new york blog main
new york top stories
pcsk9
peter wijngaard
pharmaceutical industry
praluent
prashant vaishnava
regeneron pharmaceuticals
repatha
san francisco blog main
san francisco top stories
sanofi
stanford
stanford university
What
big
2
×
drug
2
×
key
2
×
aces
announced
approach
biological
ceo
cholesterol
covering
data
deep
discovery
drugs
essentially
field
flexible
good
google
highlighting
importantly
inclisiran
learning
lowering
meant
medco
medicine
medicines
nasdaq
new
open
paper
passed
pricing
processes
promise
recipe
released
researchers
shows
Language
unset
Current search:
key
×
drug
×
big
×
@xconomy.com
4 years ago
As Cholesterol Drug Aces Big Test, MedCo CEO Open to Flexible Pricing
@gigaom.com
9 years ago
Google, Stanford say big data is key to deep learning for drug discovery
